Skip to content
Search

Latest Stories

Action imminent if employers fail to ensure safety of pharmacists: PDA

In the wake of Covid-19 pandemic and upcoming winter flu season, community pharmacy employers who fail to ensure the safety of their staff will face action under Health and Safety Legislation, the PDA warned in its latest safety update last week.

Community pharmacy staff need to be adequately protected during the current pandemic and “it is important that measures are taken to ensure that risks to this crucial sector of the workforce are mitigated as far as possible, be that by the NHS or pharmacy employers,” the Pharmacists Defence Association (PDA) said.


Much of this latest advice from the pharmacy body is based on successful initiatives used in pharmacies in other countries and remains worthy of consideration as the UK moves ahead into the winter season.

The PDA has advised community pharmacists to wear disposable gloves, aprons, and personal protection kit to prevent the risk of transmission of virus.

“The risk of transmission of virus fragments via surfaces including seating, counters, bank card machines, money, and pens provided for signing prescriptions as well as the stock that is handed over by a member of the public during a transaction makes the wearing of disposable gloves prudent,” PDA added.

The PDA has urged the people to wash their hands regularly when they are in public or visiting a pharmacy. “Regular hand washing is important for public protection but expecting staff to go and wash their hands after each potentially risky contact is impractical,” it cautioned.

Clothing

Clothes worn during the working day in a pharmacy could very easily attract and retain virus particles. Thought should be given to wearing a set of clothes in the workplace, which is then immediately removed and laundered once returning home. Different attire should then be worn at home, so as to protect other members of the family where appropriate, the PDA said in its advice to the pharmacists.

Work in shifts

The PDA has suggested the community pharmacies to enhance their business continuity and resilience by splitting the pharmacy workforce into two teams working early or late shift, with no crossover.

This shift work has reduced the risk of coronavirus infection spreading throughout the entire workforce in a particular pharmacy, the association has added.

Cleaning

The PDA has also asked the pharmacists to clean high-risk areas such as door handles, counters, pens, shopping baskets, all counters as well as communal staff areas on daily basis to ensure the safety of the pharmacy teams.

Many retail outlets are enabling members of the public to wipe down and clean their own shopping basket handles.

“All types of PPE must be donned and removed, taking care not to introduce contamination in the process. In particular, when removing masks or gloves care should be taken so as not to touch the outside surface which may carry virus particles and ensure items are disposed of safely,” the PDA added.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less